Cargando…

Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report

BACKGROUND: Progressive supranuclear palsy (PSP) is a progressive neurodegenerative condition presenting with different clinical endophenotypes. The parkinsonian variant of PSP (PSP‐P) is characterised by early but fading responsiveness to high‐dose levodopa therapy; however, high‐dose oral therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metta, Vinod, Chaudhuri, K. Ray, Leta, Valentina, Mridula, Kandadai Rukmini, Koduri, Chaitanya, Deepak, Sai, Kalpala, Rakesh, Reddy, Nageswar, Chung‐Faye, Guy, Borgohain, Rupam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480946/ https://www.ncbi.nlm.nih.gov/pubmed/35943202 http://dx.doi.org/10.1002/brb3.2547

Ejemplares similares

Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
por: Lau, Yue Hui, et al.
Publicado: (2022)

Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors
por: Metta, Vinod, et al.
Publicado: (2021)

Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
por: Morgante, Francesca, et al.
Publicado: (2020)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

Addition of Tolcapone in Intrajejunal Levodopa Infusion Therapy Requires a Pronounced Dose Reduction
por: Schröter, Nils, et al.
Publicado: (2020)

Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
por: van Poppelen, Daniël, et al.
Publicado: (2021)

Intrajejunal Infusion of Levodopa-Carbidopa Gel Can Continuously Reduce the Severity of Dropped Head in Parkinson’s Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2017)

Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome
por: Grund, K. E., et al.
Publicado: (2023)

Association of Helicobacter pylori with Parkinson's Disease
por: Mridula, Kandadai Rukmini, et al.
Publicado: (2017)

Functional Outcome of Bilateral Subthalamic Nucleus-Deep Brain Stimulation in Advanced Parkinson's Disease Patients: A Prospective Study
por: Tandra, Swetha, et al.
Publicado: (2020)

Effect of Medication and Deep Brain Stimulation on Gait in Parkinson’s Disease and its Quantitative Analysis Using Mobishoe – A Comparative Study
por: Meka, Sai Sri Lakshmi, et al.
Publicado: (2023)

Cryptoccocal menigitis as a primary manifestation in a patient with intestinal lymphangictasia
por: Jabeen, Shaik Afshan, et al.
Publicado: (2012)

Adult-onset Leigh's disease: A rare entity
por: Jabeen, Shaik Afshan, et al.
Publicado: (2016)

Dystonia Deafness Syndrome: A Rare Deep Brain Stimulation Responsive Dystonia
por: Kola, Sruthi, et al.
Publicado: (2023)

Chaudhuri’s Dashboard of Vitals in Parkinson’s syndrome: an unmet need underpinned by real life clinical tests
por: Qamar, Mubasher A., et al.
Publicado: (2023)

Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011)

Intrajejunal vs oral levodopa-carbidopa therapy in Parkinson disease: A retrospective cohort study
por: Popa, Luminita C., et al.
Publicado: (2020)

Primary diffuse leptomeningeal gliomatosis: An autopsy case report
por: Jabeen, Shaik Afshan, et al.
Publicado: (2014)

Constant Current Versus Constant Voltage DBS Stimulators—Changing Trend
por: Kandadai, Rukmini M., et al.
Publicado: (2023)

Protocol of a randomized open label multicentre trial comparing continuous intrajejunal levodopa infusion with deep brain stimulation in Parkinson’s disease - the INfusion VErsus STimulation (INVEST) study
por: van Poppelen, D., et al.
Publicado: (2020)

Fulminant Subacute Sclerosing Panencephalitis Presenting with Acute Ataxia and Hemiparesis in a 15-Year-Old Boy
por: Kandadai, Rukmini Mridula, et al.
Publicado: (2014)

Hiccups, Hypersalivation, Hallucinations in Parkinson’s Disease: New Insights, Mechanisms, Pathophysiology, and Management
por: Metta, Vinod, et al.
Publicado: (2023)

Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience
por: Metta, Vinod, et al.
Publicado: (2023)

Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders
por: Yamamoto, Tatsuya, et al.
Publicado: (2016)

Electroencephalographers: A different breed
por: Kandadai, Rukmini Mridula
Publicado: (2012)

Levodopa-Induced Facial Dystonia in a Case of Progressive Supranuclear Palsy
por: Chung, Eun Joo, et al.
Publicado: (2012)

Comparison of frequencies of non motor symptoms in Indian Parkinson’s disease patients on medical management versus deep brain stimulation: A case-control study
por: Rukmini Mridula, Kandadai, et al.
Publicado: (2015)

Response to the letter to the editor
por: Jabeen, S. A., et al.
Publicado: (2016)

Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN): Two Phenotypes—Dystonia and Spastic Paraparesis
por: Kola, Sruthi, et al.
Publicado: (2022)

Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single‐center long‐term follow‐up study
por: Rus, Tomaž, et al.
Publicado: (2022)

Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort
por: Mathukumalli, Neeharika L., et al.
Publicado: (2020)

Volumetric analysis of subthalamic nucleus and red nucleus in patients of advanced Parkinson’s disease using SWI sequences
por: Kolpakwar, Swapnil, et al.
Publicado: (2021)

Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut–incretin axis response in healthy males
por: Wu, T, et al.
Publicado: (2015)

Elevated Homocysteine by Levodopa Is Detrimental to Neurogenesis in Parkinsonian Model
por: Shin, Jin Young, et al.
Publicado: (2012)

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
por: Leta, Valentina, et al.
Publicado: (2023)

Predictors of Intracerebral Hemorrhage in Acute Stroke Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator
por: Chenna, Vijay, et al.
Publicado: (2018)

Association of 25-Hydroxyvitamin D Deficiency in Pediatric Epileptic Patients
por: CHAUDHURI, Jaydip Ray, et al.
Publicado: (2017)

Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications
por: Adamiak-Giera, Urszula, et al.
Publicado: (2021)

The Effect of Dual Tasking and Deep Brain Stimulation Frequency Parameters on Gait in Advanced Parkinson's Disease
por: Tandra, Swetha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r8cl9h4tbckbq9d6gugqcp2bgm